NLS Pharmaceutics Ltd. (NASDAQ:NLSP)
Old Forum Content for NLSP
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: $NLSP - sold my shares first thing this morning. I don't trust this one in the short term, though it does have an interesting and potentially fruitful pipeline. I just think it's run up on not so great reasons - i.e. folks thinking some great revelation will be stated at today's conference. Maybe that will happen, but that's just rolling the dice for me, particularly because I haven't done enough homework on this one.
- woodman: $NLSP has been moving since last Friday when it postponed an updates-conference (that was to take place that day) until this Thursday (tomorrow). The company said the postponement was due to "important developments impacting the timing of the company update." The speculation, obviously, is that good - maybe big - news is coming. It has a narcolepsy/ideopathic hypersomnia/ADHD drug in the works, going from phase 2 now to phase 3. And it has a number of other "innovative therapies for rare and complex central nervous system disorders" in early works. This could see $2.00 in the very short term, but potentially much higher on good news. I was distracted and unfocused on Friday and should have bought it then, and I was not around on Monday to buy, so I didn't get around to buying it until this morning.
- Herb: $ZIM $NLSP two strong foreign ipos. np.
| Stock Price | $5.20 |
| Change | 4,060.00% |
| Volume | 170,808 |
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. The company focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.
Request Video of NLSPAlready a member? Sign in here.
Past Month
Leading Peers
-
$31.45 548.86%
-
$5.96 382.53%
-
$5.20 354.58%
Past Month
Lagging Peers
-
$20.92 -101.99%
-
$10.50 -47.36%
-
$5.23 -42.75%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!